Menopausal Hormone Therapy after Breast Cancer

DSpace/Manakin Repository

Menopausal Hormone Therapy after Breast Cancer

Citable link to this page

 

 
Title: Menopausal Hormone Therapy after Breast Cancer
Author: Colditz, Graham A.
Citation: Colditz, Graham A. 2005. Menopausal hormone therapy after breast cancer. Breast Cancer Research 7(4): 168-170.
Full Text & Related Files:
Abstract: The use of postmenopausal hormone therapy after breast cancer remains controversial. Evidence shows variation by study design, and even among three randomized controlled trials there is substantial heterogeneity of results. Two Swedish trials of comparable size show relative risks of recurrence of 3.3 and 0.82 on comparing women receiving postmenopausal hormone therapy with control women. The extent of use of tamoxifen and concomitant use of progestins in combination with estrogen, although raised as one possible explanation for this heterogeneity, are not supported by evidence from trials of high-dose progestins used after breast cancer. Caution is needed when considering the use of postmenopausal hormone therapy after breast cancer.
Published Version: doi:10.1186/bcr1272
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175078/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4595431
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters